DBIA
TMO icon

Dumont & Blake Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
2,281
-38
-2% -$20.6K 0.28% 87
2025
Q4 		$1.34M Sell
2,319
-10
-0.4% -$5.66K 0.32% 78
2025
Q3 		$1.13M Sell
2,329
-23
-1% -$10.7K 0.27% 86
2025
Q2 		$954K Buy
2,352
+20
+0.9% +$8.36K 0.25% 97
2025
Q1 		$1.16M Sell
2,332
-15
-0.6% -$8.12K 0.33% 78
2024
Q4 		$1.22M Sell
2,347
-26
-1% -$14.3K 0.33% 79
2024
Q3 		$1.47M Sell
2,373
-2,415
-50% -$1.43M 0.39% 68
2024
Q2 		$2.65M Buy
4,788
+2,389
+100% +$1.37M 0.37% 71
2024
Q1 		$1.39M Sell
2,399
-24
-1% -$13.5K 0.4% 68
2023
Q4 		$1.29M Sell
2,423
-55
-2% -$26.6K 0.4% 64
2023
Q3 		$1.25M Sell
2,478
-20
-0.8% -$10.7K 0.42% 65
2023
Q2 		$1.3M Buy
2,498
+1
+0% +$540 0.42% 68
2023
Q1 		$1.44M Sell
2,497
-40
-2% -$22.5K 0.49% 59
2022
Q4 		$1.4M Sell
2,537
-40
-2% -$21.2K 0.49% 59
2022
Q3 		$1.31M Sell
2,577
-1
-0% -$560 0.49% 58
2022
Q2 		$1.4M Sell
2,578
-28
-1% -$15.4K 0.46% 62
2022
Q1 		$1.54M Sell
2,606
-25
-1% -$14.4K 0.42% 69
2021
Q4 		$1.76M Sell
2,631
-3
-0.1% -$1.87K 0.46% 55
2021
Q3 		$1.5M Sell
2,634
-15
-0.6% -$8.23K 0.43% 67
2021
Q2 		$1.34M Buy
2,649
+21
+0.8% +$9.91K 0.38% 78
2021
Q1 		$1.2M Buy
2,628
+30
+1% +$14.3K 0.37% 82
2020
Q4 		$1.21M Sell
2,598
-155
-6% -$72.7K 0.41% 73
2020
Q3 		$1.22M Buy
2,753
+12
+0.4% +$4.96K 0.46% 63
2020
Q2 		$993K Buy
2,741
+7
+0.3% +$2.35K 0.41% 72
2020
Q1 		$775K Sell
2,734
-35
-1% -$11K 0.4% 76
2019
Q4 		$900K Sell
2,769
-20
-0.7% -$6.06K 0.35% 86
2019
Q3 		$812K Sell
2,789
-680
-20% -$195K 0.34% 92
2019
Q2 		$1.02M Hold
3,469
– – 0.42% 71
2019
Q1 		$950K Hold
3,469
– – 0.4% 82
2018
Q4 		$776K Buy
3,469
+65
+2% +$15.3K 0.36% 92
2018
Q3 		$831K Sell
3,404
-1,700
-33% -$391K 0.32% 103
2018
Q2 		$1.06M Sell
5,104
-217
-4% -$46.1K 0.44% 76
2018
Q1 		$1.1M Hold
5,321
– – 0.47% 71
2017
Q4 		$1.01M Sell
5,321
-90
-2% -$17.2K 0.41% 85
2017
Q3 		$1.02M Sell
5,411
-40
-0.7% -$7.24K 0.44% 84
2017
Q2 		$951K Sell
5,451
-75
-1% -$12.6K 0.42% 86
2017
Q1 		$849K Buy
5,526
+15
+0.3% +$2.29K 0.38% 91
2016
Q4 		$778K Sell
5,511
-40
-0.7% -$5.9K 0.36% 96
2016
Q3 		$883K Sell
5,551
-75
-1% -$11.6K 0.43% 87
2016
Q2 		$831K Sell
5,626
-170
-3% -$25.1K 0.42% 86
2016
Q1 		$821K Sell
5,796
-107
-2% -$14.3K 0.42% 84
2015
Q4 		$837K Hold
5,903
– – 0.43% 84
2015
Q3 		$722K Sell
5,903
-62
-1% -$8.08K 0.39% 95
2015
Q2 		$774K Hold
5,965
– – 0.38% 100
2015
Q1 		$801K Buy
5,965
+45
+0.8% +$5.8K 0.39% 98
2014
Q4 		$742K Sell
5,920
-20
-0.3% -$2.43K 0.37% 101
2014
Q3 		$723K Sell
5,940
-105
-2% -$12.8K 0.37% 103
2014
Q2 		$713K Sell
6,045
-3,245
-35% -$382K 0.36% 104
2014
Q1 		$1.12M Sell
9,290
-325
-3% -$38.6K 0.58% 64
2013
Q4 		$1.07M Sell
9,615
-5,710
-37% -$568K 0.55% 75
2013
Q3 		$1.41M Hold
15,325
– – 0.67% 54
2013
Q2 		$1.3M Buy
+15,325
New +$1.28M 0.78% 44

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dumont & Blake Investment Advisors's TMO Position: Q1 2026 in Review

Dumont & Blake Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q1 2026, selling an estimated $20.6K and leaving 2,281 shares worth $1.12M. The position accounts for 0.28% of the portfolio, ranked #87.

Dumont & Blake Investment Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.65M in Q2 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Dumont & Blake Investment Advisors held 2,281 shares of Thermo Fisher Scientific worth $1.12M as of Q1 2026.
  • Dumont & Blake Investment Advisors sold 38 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.6K.
  • Thermo Fisher Scientific made up 0.28% of Dumont & Blake Investment Advisors's portfolio in Q1 2026, its #87 holding.
  • Dumont & Blake Investment Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Dumont & Blake Investment Advisors's Thermo Fisher Scientific position peaked at $2.65M in Q2 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.